Director Ronald Blaylock buys 39,231 Pfizer Inc. (NYSE: PFE) shares

Rhea-AI Filing Summary

Pfizer Inc. director Ronald E. Blaylock purchased 39,231 shares of Common Stock on August 5, 2026 at $25.46 per share in an open market or private transaction. After this buy, he directly holds 66,938 shares and indirectly holds 4,750 shares by trust. The trade was not made under a Rule 10b5-1 plan.

Insider Trade Summary

Net Buyer: 39,231 shares

Net Buy 2 txns

Insider BLAYLOCK RONALD E

Role Director

Bought 39,231 shs ($999K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	39,231	$25.46	$999K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 66,938 shares (Direct); Common Stock — 4,750 shares (Indirect, By Trust)

Key Figures

Shares purchased: 39,231 shares Purchase price: $25.46 per share Direct holdings after transaction: 66,938 shares +2 more

5 metrics

Shares purchased 39,231 shares Common Stock purchased on August 5, 2026

Purchase price $25.46 per share Price for the 39,231-share Common Stock purchase

Direct holdings after transaction 66,938 shares Direct Pfizer Common Stock held by Ronald E. Blaylock after the purchase

Indirect holdings by trust 4,750 shares Pfizer Common Stock held indirectly by trust

Net buy shares reported 39,231 shares Net buy direction across reported transactions in this Form 4

Key Terms

open market or private transaction, indirect ownership, By Trust

3 terms

open market or private transaction financial

"Purchase in open market or private transaction"

indirect ownership financial

"Ownership type marked as indirect, with shares held by trust indicating indirect ownership"

By Trust financial

"Nature of ownership noted as By Trust for 4,750 shares"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/05/2026 - 04:04 PM Accepted by SEC EDGAR 08/05/2026 - 04:03 PM Learn about SEC filing dates

FAQ

What insider transaction in Pfizer (PFE) did Ronald E. Blaylock report?

Ronald E. Blaylock reported buying 39,231 shares of Pfizer Common Stock on August 5, 2026 at $25.46 per share. The transaction is described as a purchase in an open market or private transaction and was not made under a Rule 10b5-1 trading plan.

How many Pfizer (PFE) shares does Ronald E. Blaylock own after this transaction?

After the transaction, Ronald E. Blaylock directly owns 66,938 Pfizer shares. In addition, there is an indirect holding of 4,750 shares held by trust, giving him combined direct and reported indirect exposure to Pfizer stock in this Form 4.

At what price did Ronald E. Blaylock purchase his latest Pfizer (PFE) shares?

Ronald E. Blaylock purchased the 39,231 Pfizer shares at a price of $25.46 per share. This was recorded as a purchase in an open market or private transaction on August 5, 2026, according to the details of the reported Form 4 filing.

Was Ronald E. Blaylock’s Pfizer (PFE) share purchase under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is not affirmed, indicating the trade was not made under a Rule 10b5-1 trading plan. This suggests the purchase was discretionary rather than executed pursuant to a pre-arranged trading program.

What indirect Pfizer (PFE) holdings by Ronald E. Blaylock are disclosed?

The Form 4 discloses an indirect position of 4,750 Pfizer shares held “By Trust”. This is separate from Ronald E. Blaylock’s 66,938 directly held shares and reflects ownership through a trust structure noted as indirect ownership in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BLAYLOCK RONALD E

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2026		P		39,231	A	$25.46	66,938	D
Common Stock								4,750	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Shanice A. Reid, by power of atty., for Ronald E. Blaylock	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)